Literature DB >> 27923456

Strategies to use microRNAs as therapeutic targets.

Erica Gentilin1, Ettore Degli Uberti1, Maria Chiara Zatelli2.   

Abstract

MicroRNAs (miRNAs) are non-coding RNAs generated from endogenous hairpin-shaped transcripts that powerfully regulate gene expression at post-transcriptional level. Each miRNA is capable to regulate the expression levels of hundreds of transcripts and each mRNA may have more than one miRNA recognition sequence. There is emerging evidence that deregulation of miRNA expression leads to the alteration of pivotal physiological functions contributing to the development of diseases and neoplasms, including pituitary adenoma. This review is aimed at providing the up-to-date knowledge concerning deregulated miRNAs of pituitary tumors and their functions. In order to take stock, pituitary tumors have been sub-divided in different classes on the basis of tumor features (histotype, dimension, aggressiveness). The overview takes full consideration of the recent advances in miRNAs role as potential therapeutics and biomarkers. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  miRNA; miRNA biomarkers; miRNA-based therapy; pituitary

Mesh:

Substances:

Year:  2016        PMID: 27923456     DOI: 10.1016/j.beem.2016.10.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  19 in total

Review 1.  Pathogenesis of non-functioning pituitary adenomas.

Authors:  Maria Chiara Zatelli
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

2.  MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK.

Authors:  Wei Zhang; Kai Liao; Dongning Liu
Journal:  Cancer Manag Res       Date:  2020-09-08       Impact factor: 3.989

3.  Analysis of whole genome-wide microRNA transcriptome profiling in invasive pituitary adenomas and non-invasive pituitary adenomas.

Authors:  Chao Zhang; Yuan Qian; Yisheng Qiao; Yao Li; Wei Wang; Junjun Li; Xingli Deng
Journal:  Chin Neurosurg J       Date:  2019-12-02

4.  MicroRNA-296-5p inhibits cell proliferation by targeting HMGA1 in colorectal cancer.

Authors:  Guohui Yan; Shuidi Yan; Jiajia Wang; Shen Lei; Weimin Tian; Xin Yue; Yang Zhang
Journal:  Exp Ther Med       Date:  2021-05-24       Impact factor: 2.447

5.  MiR-1179 inhibits the proliferation of gastric cancer cells by targeting HMGB1.

Authors:  Yongsheng Li; Ce Qin
Journal:  Hum Cell       Date:  2019-03-22       Impact factor: 4.174

6.  Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN/PDCD4.

Authors:  Zuopeng Wang; Wei Yao; Kai Li; Na Zheng; Chao Zheng; Xiaolong Zhao; Shan Zheng
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

7.  miR‑221‑3p promotes the cell growth of non‑small cell lung cancer by targeting p27.

Authors:  Guoqing Yin; Bo Zhang; Jia Li
Journal:  Mol Med Rep       Date:  2019-05-23       Impact factor: 2.952

8.  Screening circular RNA expression patterns following focal cerebral ischemia in mice.

Authors:  Cuiying Liu; Chencheng Zhang; Jian Yang; Xiaokun Geng; Huishan Du; Xunming Ji; Heng Zhao
Journal:  Oncotarget       Date:  2017-09-23

9.  Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology.

Authors:  Filip Garbicz; Dawid Mehlich; Beata Rak; Emir Sajjad; Maria Maksymowicz; Wiktor Paskal; Grzegorz Zieliński; Paweł K Włodarski
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

10.  Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.

Authors:  Olivia Anderson; Irene K Guttilla Reed
Journal:  PLoS One       Date:  2020-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.